/
Neuronetics, Inc. (the Company or Neuronetics or the Registrant ) believes that mental health is as important as physical health. As a global leader in neuroscience, the Company is delivering more treatment options to patients and healthcare providers by offering exceptional in-office treatments that produce extraordinary results.
The business is unprofitable at the operating level (-21.08% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue up 99.2% YoY with margins expanding 25.1pp.
Negative free cash flow of -$21M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$152M
▲ +99.2% YoY
Net Income (TTM)
-$37M
▲ +10.8% YoY
Op. Margin
-19.40%
▲ +25.1pp YoY
ROIC
-21.26%
▲ +4.1pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$14M
▲ +34.8% YoY
Op. Cash Flow (TTM)
-$13M
▲ +34.3% YoY
Net Debt
$72M
Cash & Equiv.
$13M
5Y CAGR: +24.8%
Continue Research